Moderna Australia has announced that the TGA has authorised its updated COVID-19 vaccine, SPIKEVAX JN.1, targeting the JN.1 variant of SARS-CoV-2 for people aged 12 and over.
TGA approves Moderna's updated SPIKEVAX JN.1 COVID-19 vaccine
November 18, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
AusBiotech and MTPConnect bring together life sciences sector for national summit
November 19, 2024 - - Latest News -
BMS Australia to host a summit focused on patients and the parliament
November 19, 2024 - - Latest News -
PBAC member and former industry executive appointed to board of local biotech
November 18, 2024 - - Latest News -
TGA approves Moderna's updated SPIKEVAX JN.1 COVID-19 vaccine
November 18, 2024 - - Latest News -
Radiopharm says targeted therapy demonstrates potential for pancreatic cancer patients
November 18, 2024 - -
CLINUVEL announces plan to prioritises three strategic programs
November 18, 2024 - - Latest News -
The records and decisions in one year show that everything happens for a reason
November 18, 2024 - - Latest News